French medtech Implicity has raised €35 million from IRIS and Five Arrows to accelerate its expansion in the United States and broaden its product roadmap. Founded by cardiologist Arnaud Rosier, the company has built a platform that aggregates data generated by cardiac devices from multiple manufacturers and helps clinical teams prioritize alerts, reducing the burden of manual triage.
Already deployed in more than 250 medical centers, Implicity has established itself as a remote cardiac monitoring specialist. The new funding is intended not only to support commercial growth, especially in the US market, but also to move the company beyond alert sorting toward predictive cardiology, using device data to anticipate patient risk rather than simply react to incoming notifications.
The raise underscores investor confidence in a segment where hospitals are under pressure to manage growing volumes of device-generated data and clinical alerts more efficiently. By combining interoperability across brands with decision-support tools, Implicity aims to position itself as a key infrastructure layer for digital cardiology.